一项大型研究发现,使用自动胰岛素系统的1型糖尿病患者比使用注射者更有可能达到血糖目标。 Type 1 diabetes patients using automated insulin systems were far more likely to meet blood sugar goals than those using injections, a large study found.

一项2025年12月22日的研究发现,使用 " 控制IQ " 等自动胰岛素运载系统的1型糖尿病患者比每天多注射胰岛素的患者更可能达到HEDIS血清目标。 A December 22, 2025, study found that type 1 diabetes patients using automated insulin delivery systems like Control-IQ were significantly more likely to meet the HEDIS glycemic goal than those using multiple daily insulin injections. 根据12 000多名病人提供的数据进行的研究显示,达到建议的血糖目标的比例急剧上升,控制不良的病例急剧下降。 The research, based on data from over 12,000 patients, showed a sharp increase in the proportion achieving recommended blood glucose targets, with a dramatic drop in poor control cases. 不同保险类型的结果是一致的,支持这些技术在改善现实世界糖尿病管理方面的有效性。 Results were consistent across different insurance types, supporting the effectiveness of these technologies in improving real-world diabetes management.